Cryptococcus neoformans is an encapsulated yeast that is pathogenic for humans. The capsule is a major virulence factor composed mainly of glucuronoxylomannan (G XM ) and two minor constituents, galactoxylomannan, and mannoprotein (M P). A hallmark of disseminated cryptococcosis is the presence of high concentrations of G XM in body uids of infected hosts. G XM provides a critical negative signal for T cell activation and neutrophil migration at the site of the in ammatory process. There is also strong evidence that M P promotes critical events associated with protective responses such as delayed type hypersensitivity and presumably a T helper type 1 response. The contrasting roles of G XM and M P in regulation of the immune response to C. neoformans offer a promising template for a successful approach to intervention, by scavenging G XM to attenuate its negative signals, while preserving the positive effects of M P.
Introduction
Cryptococcus neoform ans is an opport unistic funga l pathogen that is responsible for serious infections in individua ls with impaired cell-mediated immunity, including human immunode ciency virus (HIV)-infected patients [1] , renal transplant patients [2] and subjects receiving immunosuppr essive therapy [3] . C. neoformans is an ubiquitou s fungus that is often found in soil contaminated with pigeon droppin gs [4] . This fungus is remarkable in that it has a large polysa ccharide capsule which acts as a major virulence factor. It is believed that environmental isolates have a small capsule which enables aerosolized particles of a small size to reach the alveoli [5, 6] .
Capsule synthesis depends on many factors including the concentrations of CO 2 and HCO 3 ¼ [7] and iron availability [8, 9] . In particular, high levels of CO 2 as well as iron chelators [9] favor capsule product ion [7] . Phenotypic switching has been reported to alter capsule size and composition [10] . Whether the increase in capsule size that accompanies infection is a result of pH , iron deprivatio n, or a switching event is not known. Studies on the cellular location of capsule synthesis are scarce and the exact site is still not clear. It is possible that capsular polysa ccharide is synthesized in the cytopla sm and exported to the external cell wall in vesicles for assembly [11, 12] .
The capsule is composed primarily of capsular polysa ccharide, the major virulence factor endowed with antiphagocytic and immunosuppressive properties, although non-polysa ccharidic components, including proteins, have also been identi ed [13] . Capsular polysa ccharide is released by encapsulated yeasts. One remarkable aspect of the C. neoformans capsule is that addition of puri ed polysa ccharide to acapsular yeast results in partial recon-stitution of the capsular structure such that the acapsular cells become resistant to phagocytosis [14, 15] .
The major constituents of capsular polysaccharide are glucuronoxylo mannan (GXM ), galactoxyloma nnan (GalXM ) and mannopro tein (M P). G XM represents 88% of capsular material and high levels have been detected in the body uids of patients with cryptococcosis [16] . It is released during yeast replication with a marked deposition in infected tissues, such as the spleen and liver [17] . Antigenic differences in G XM characterize four different serotypes: A, B, C and D . R abbit immune sera are employed for classi cation because rabbits, in contrast to mice, mount a strong antibody response to capsular polysaccharide [18, 19] . H owever, serologica l studies have shown that many antigenic epitopes are shared with various strains and, consequently, only a few serotypes have been described. In addition, there can be differences in the polysa ccharide structure among isolates assigned to a speci c serotype [20] .
GalXM is a heterogeneous polysa ccharide composed of galactose, glucose, xylose and mannose. It is a minor component of capsular material and is shed during infection as is the case with GXM . It is found in the body uids of infected hosts in the same way as G XM [21] . GalXM is not covalently bound to the cell wall [22] and its association with other yeast-cell components remains unknown . GalXM is easily separated from GXM by Con A on column chromatography [22] . The biologica l effects of GXM have been extensively studied but relatively little work has been done with GalXM . M P is anot her minor component of capsular material. The site of M P synthesis is the cytopla sm [13] . M P has been separated from G alXM by Con A af nity column chromatogr aphy. During this process, three peaks were observed and the last peak contained M P [23] . M annose is the main component of M P, with galactose and xylose being minor constituents [24] . The nature of the linka ge between carbohydrates and prot eins is unknown . Proteins, other than M P, are associated with the cell wall of C. neoformans and the mitogenic properties of these fractions have been described [25, 26] . GXM , GalXM and M P are shed during C. neoformans replication and may be recovered in culture supernatants [27] . Several glycoprotein antigens from cultur e supernatants of C. neoformans have been detected and puri ed [28 -30] . M oreover, glycoprot ein has also been detected in the sera of C. neoform ans -infected patients [30] .
In summary, the capsule of C. neoformans contains primarily the polysaccharides, GXM and GalXM , together with M P; all three have been recovered in different amounts either associated with the yeast or released in culture supernatants. The most representative fraction is G XM , followed by GalXM and M P. These fractions generate potent immunoregu latory activity affecting bot h the innate and adaptive immune response. This review focuses on the effects of capsular material and its speci c polysa ccharide components on the innate and T cell immune response and examines the regulatory mechanisms involved.
Immunoregulation by GXM

Humoral immune response
Complement acti×ation
N on-encapsulated C. neoform ans initiat es complement activation through the classical and alternative pathways. Activation of the classical pathway begins suddenly and is characterized by deposit ion of C3 fragments over the entire cell surface [31] , and may be due to the presence of antibodies reactive with glucan in normal human serum binding to the yeast surface [32] . In contr ast, C. neoformans encapsulated strains are not able to activate the classical complement pathway. This may result from the absence of speci c antibodies to G XM in normal human serum or to its inability to initiat e activation of the classical complement pathway [33] . Nevertheless, bot h non-enca psulated and encapsulated strains are able to initiate alternative complement activation with an early and limited number of focal sites for C3 deposition on the cell wall or cryptococcal capsule, respectively.
Despite the fact that encapsulated cryptococci are potent activators of the complement pathway [34] , puri ed G XM is relatively poor in its ability to activate the complement system [35] . F ree GXM may have different biological properties than GXM assembled into a capsular structure.
Complement activation in normal non-im mune serum leads to deposit ion of C3 on the capsule that in turn facilitates the phagocyt ic process by macropha ges and neutrop hils [35 -38] . On the other hand, natural effector cells, including monocytes, have functiona l CR 1, CR 3 and CR 4 complement receptors, and their blockage results in a signi cant decrease of binding serum to opsonized C. neoformans [39] . The importance of CR 3 receptors for the phagocytic process and for in ×i×o resistance to infection was underscor ed by Cross et al. [40] . In addition, CR 3 receptor expression is largely upregulated by cytokines such as tumor necrosis factor-a (TNF -a ) and granulocyte-m acrophage colony-stim ulating factor which ef ciently enhance ingestion of serum opsonized C. neoformans [40] . These cytokines may be lacking in immunocompromised patients. F urther evidence support ing the role of complement opsoniza tion in induct ion of phagocyt osis was provided by Ikeda et al. [41] , who demonstr ated a direct association between the ability of a weakly encapsulated strain to induce complement activation and promotion of phagocyto sis. M oreover, studies by K ozel et al. [42] on phagocyt osisresistant or phagocyto sis-sensitive strains show similar activation and binding of C3 opsonic fragments suggesting that other serum factors contribute to differences in phagocytosis.
The importance of an intact complement system in host resistance to C. neoformans infection has been well document ed in experimental animal models [43 -45] . Crypt ococcosis in acquired immune de ciency syndrome (AID S) patients has been associated with a complement de cient state that may be due to direct activation of the complement system by C. neoformans leading to consumption of complement factors [46] . The contribu tion of the complement system in resistance to C. neoformans infection is multifaceted and has been ascribed not only to opsoniza tion [36, 37, 39] but also to cleavage factors generated by complement that are activating and chemotactic for leukocytes.
A ntibodies to GX M
Several studies have evaluated the antibody response to vaccination with cryptococcal polysa ccharide [47, 48] . G XM has been shown to be poorly immunogenic and 'immunologica l paralysis' has been described in mice immunized with large doses of polysa ccharide [49] . The immunosup pressive effect of G XM on antibody response was described by M urphy & Cozad [50] . In mice the antibody response may exhibit considerable variations depending on the strain employed, consistent with genetic control [51] .
Capsular polysa ccharide is a T-cell-independen t antigen [51 -53] . However, T cells have been shown to regulate the antibod y response, as suggested by experiments in which mice treated with anti-lympho cyte serum mount a strong antibody response to cryptococcal polysaccharide [53] . The importa nce of this response is suggested by the fact that rabbits, in contrast to mice, mount a good antibody response to capsular polysa ccharide that correlates with resistance to infection [46] . This resistance does not appear to be due to high body temperature since the immunosup pressive treatment renders these animals susceptible to cryptococcosis [54] . Thus, rabbits have become a standard species for the generation of polyclona l sera used in passive antibody protection experiments [55, 56] and human therapy [57] .
The role of antibody to GXM has been extensively studied in experimental cryptococcosis and its bene cial effect has been clearly demonstrated. The protective effect has been shown to prolong surviva l, reduce tissue cfu burden [58 -67] , and enhance the therapeut ic ef cacy of convention al antifunga l agents [68 -70] . The importance of the natural human antibody response to infection is less certain but there is evidence that a strong response is bene cial. Antibod ies to GXM are important opsonic factors that are present in the serum of HIV-negative and H IV-positive individua ls [58] . Patients with cryptococcosis often have a low antibody response [71] and the absence of serum antibody has been associated with a poor prognosis [72] . The poor immunogenicit y of GXM may be offset by conjugatin g GXM to protein which results in a highly immunogenic vaccine that is able to elicit protective antibody response in mice [73, 74] .
M any factors concur with the protective ef cacy of antibody to GXM including direct scavenging of G XM from serum and tissue [17, 59, 60, 65, 75] , promotion of granuloma formation [76, 77] , phagocytosis and killing [78 -83] , complement activation [41] , and enhancement of the cellular immune response. The latter is probably the result of a complex interaction of monoclon al antibody (M ab) to GXM with phagocytic cells resulting in induction of proin ammatory cytokine synthesis [83] and modulation of antigen presenting cell (APC) function. A positive regulation by anti-G XM M ab affecting a variety of APC functions such as major histocompatibility complex (M HC) class II and B7 molecule expression [84] and interleukin (IL)-12 product ion [85] has been observed. Thus, M abs to GXM may have bene cial effects as scavengers of G XM , with consequent inhibition of its deleterious effects, as well as by enhancement of the cellular immune response. The combination of these effects may be crucial in inducing opt imal T-cell activation and in generating a T-helper type 1 (Th1) protective response. In fact, enhancement of T-cell proliferation was observed in the presence of M ab against GXM that paralleled an increase of IL-2 and interferon-g (IF N-g ) product ion [83 -85] .
It is conceivable that M abs against G XM induce positive regulation of the T-cell response to C. neoformans possibly through modula tion of APC function. The effect on T cells appears to be crucial for protection, as observed in experimental models in which the protective effect of M abs against G XM was lost in CD4 de cient mice [86] . M oreover, passive administration of M ab against GXM has been shown to be effective in promoting partial elimination of circulating and tissue-associated G XM from the infected host . This may be effective in eliminating many immunosup pressive effects exerted by G XM on immune cells including inhibition of T-cell activation [87, 88] , pro-in ammatory cytokine secretion [89] , enhancement of inhibitor y factors [90] , down-regulation of APC function [84, 88, 91] and possibly Th1 damp-ening, as demonst rated by IF N -g inhibition and IL-4 induction [92] . However, it is noteworthy that under some circumstances the binding of antibody to GXM can form antigen -antibod y complexes which are deleterious to the host. Savoy et al. [93] reported that administr ation of immunoglobu lin (Ig)G 1 antibod y to chronically infected mice could result in acute lethal toxicity [93] . This phenomenon is related to the antibody isotype and appears to be caused by toxicity from platelet activating factor released as a consequence of F c receptor crosslinking by antigen -antibody complexes [94, 95] .
In conclusion, the protective activity of M ab against GXM is the result of multiple effects that imply partial elimination of GXM and the associated immunosup pressive effects as well as positive regulation of a myriad of cellular immune functions.
C ellular innate immune system
M onocytes and macrophages
M onocytes and macrophages play a critical role in host defense to C. neoformans. Their involvement in the immune response is varied and characterized by interaction with the fungus, primarily GXM capsular material. M onocytes and macrophages encounter ing C. neoformans have a twofold funct ion: (i) effector cells ingest and may kill the fungus; (ii) regulatory cells through accessory and secretory activities orchestrate a positive and negative T-cell response. The inability of macropha ges to kill the fungus may be associated with persistent infection and the establishment of latency [96] .
Phagocyto sis of C. neoformans by monocytes and macrophages has been extensively studied using acapsular and encapsulated C. neoform ans [88] . There is conclusive evidence that capsular material, in particular G XM , inhibits the phagocytic process [53] and that complement and speci c antibody opsoniza tion play a critical role in facilitating the process [97, 98] . Less clear is whether free or attached GXM is more important for virulence. F urthermore, after ingestion macrophages do not necessarily kill encapsulated C. neoformans ; indeed the fungus can reside and survive in the acid phagolysoso me [99] . R ecently persistence of C. neoformans in macrophages has been documented in latent infection [96] .
The role of capsular material, and likely G XM , in suppression of phagocyto sis and killing of C. neoformans is minimized when macrophages are activated with IF N-g , resulting in extracellular fungicida l activity in the absence of antibody or complement opsonins [100] . F rom these results one could argue that upon activation of phagocytic cells C. neoformans is eliminated, although under normal condition s the capacity of C. neoformans to survive inside macropha ges is strongly dependent on the presence of the polysaccharide capsule. Studies by Goldman et al. [96] have shown a progressive increase in the amount of cryptococcal polysa ccharide within phagolysosom es of macrophages. This increase is associated with alteration of the phagolysosoma l membrane and with the destruction of macropha ges [96, 101] .
In addition to interfering with the internalization of C. neoformans by macrophages, capsular polysaccharide is believed to play a critical role in regulating the secretory and APC function of monocytes:macropha ges. These functions have not been as extensively investiga ted as the phagocytic process; however, there is evidence for G XM regulation of cytokine secretion and costimulation during the antigen presentation process [88] .
The suppressive activity of capsular material, and in particular GXM , has been demonst rated with respect to pro-in ammatory cytokine release from monocytes [89] . G XM inhibit s TN F -a induced by encapsulated C. neoformans as well as by an unrelated stimulus such as lipopolysa ccharide (LPS) [89] , suggest ing that free GXM exerts a down regulatory effect independen t of its antiphagocytic effect and apart from the presence of C. neoformans. This is consistent with the ability of G XM to directly induce IL-10 release that exerts an inhibitory role on pro-in ammatory cytokine product ion [90] .
Given that IL-10 is the most potent biological inhibitor of IL-12 [102] , GXM could exert a suppressive effect on IL-12 secretion through IL-10 induction . Our recent report demonstrates that IL-12 is produced by monocytes in response to C. neoformans in both a T cell-independen t and T cell-dependent manner [85] , and that acapsular C. neoformans is a better inducer of IL-12 product ion than the encapsulated strain. U npublished observations [C. R etini et al., unpublished results] show that free G XM exerts a suppressive effect on IL-12 produced in response to acapsular C. neoformans. G iven that IL-12 is a key factor in the generation of a Th1 cell response [103] and that this response has been reported to be protective against C. neoformans infection [104, 105] , it is conceivable that capsular polysa ccharide, and possibly G XM through its effects on IL-12 regulation, contribu tes to the control of T cell activation and differentiation of T helper cells towards a non-pro tective Th2 phenotype response. M acrophages control Th2 developm ent by release of IL-6 that may direct Th2 differentiation [106] . M oreover , G XM has been shown to induce IL-6 production by monocytes [107] . R ecently, Lendvai et al. [95] reported that intravenous inocula tion of G XM induced IL-6, IL-1 b and TN F -a expression in the liver but not in the spleen. A summary of the effect of G XM on cytokine synthesis is reported in Table 1 .
To sustain a T cell speci c response two types of interaction between APCs and T cells are necessary. The rst signal is mediated via T cell receptors after recognition of an antigenic peptide presented by M HC. The second signal, referred to as co-stimulation, includes B7 and CD 40 molecules. The B7 family of proteins, B7-1 (CD80) and B7-2 (CD86), is expressed on APCs providing a major costimulatory signal that augments or limits the T cell response via interaction with CD 28 or CTLA-4 molecules, respectively, on T cells [115] .
R ecently we demonstr ated that the polysa ccharide capsule of C. neoform ans regulates B7 molecule expression on APCs. In particular, a suppr essive effect has been observed in M H C class II [84] and B7 molecule expression [84, 116] and there is direct evidence that GXM is responsible for M H C class II down-regula tion [92] . The complexity of the regulatory role of G XM is suggested by our recent demonstration that free GXM produces upregulation of CD 40 molecule expression on monocytes, but when used in combination with the acapsular strain CD40 expression is suppressed [91] . The emerging view is that the polysa ccharide capsule, and in particular GXM , can in uence the type of immune response through their effects on T cell growth and differentiation.
The manner in which the polysa ccharide capsule or G XM regulates APC function appears to be largely but not exclusively related to the inhibition of phagocyto sis. This is support ed by the fact that several G XM -induced immunosup pressive functions are easily reversed using speci c antibod ies to GXM [83 -85,116 -118] . In fact, there is evidence of antibody-m ediated effects in restoring G XM inhibition of B7 molecule expression on APC [84, 116] . In addition , speci c antibodies to GXM promote internalization of C. neoformans by APC and restore the T cell response [83, 117] . H owever, the interaction of G XM with monocytes:macropha ges involves: (i) the biologica l effect of free G XM , and (ii) the immunoregula tory role of GXM associated with capsular material of C. neoformans which is dependent on the phagocytic process.
In the rst case, the direct interaction of free G XM induces IL-10 release from monocyt es [90] , inhibits TNF -a secretion in response to unrelated stimulus such as LPS [96] , and regulates CD 40 expression on the monocyte surface [91] . This effect infers a direct ligation of G XM on monocytes:macrophages. However, studies delineating the speci c receptor for GXM on macrophages have not yet been published.
In the second case, the effect of capsular polysa ccharide or GXM is directly dependent on the phagocytic process. This is suppor ted by: (i) a relationship between the amount of IL-1 and TNF released by monocytes and the capacity to internalize the fungus; (ii) the capacity of APCs to induce T cell activation paralleling C. neoformans ingestion by APCs; and (iii) M ab against GXM in combination with encapsulated strains reversing the suppressive effect of G XM on pro-in ammatory cytokine release. Impor tantly, the positive or negative in uence of [91] Unchanged [91] Not tested GXM plus unrelated stimulus ‡ Increased [90] *, GXM was used in combination with acapsular C. neoformans and the effect was compared to the acap sular strain alone. †, Effect of free G XM on phagocytic cells. The effect was compared to unstimulated cells. ‡, GXM was used in combination with LPS and the effect was compared to LPS alone.The relevant referen ces are reported in parentheses. G XM on APCs plays a key role in determining the cytokine response [84] and may be appropr iate for Th1 development. The events that characterize the immunological protective response are summarized in Tables 2  and 3 .
Overall, GXM limits the response of in ammatory cytokines and by inhibiting IL-12 and B7-1 molecule expression impairs development of the Th1 response. M oreover , by decreasing M H C class II and CD40 expression GXM may prevent or quench T cell activation. H owever, studies in ×i×o indicate that G XM is able to induce proin ammatory cytokine release in the liver but not in the spleen [95] , underscoring the complex role of G XM as an immunom odulato r and suggesting the compartmentalization of the immune response to G XM .
Polymorphonuclear cells
Polym orphon uclear (PM N) cells are effective components of the natural immune defense system against C. neoform ans. PM N ef ciently kill C. neoform ans by intracellular and extracellular mechanisms [118, 119] , secrete soluble factors in response to the yeast or its capsular polysa ccharide [110] , and are attracted to the site of infected tissue [120] . K illing activity against C. neoformans is largely dependent on the presence of the polysa ccharide capsule. It has been shown that acapsular strains are readily killed by PM N cells compared to encapsulated strains [121, 122] . This could be due to the dif culty PM N cells encount er in ingesting encapsulated C. neoformans, given that M ab against GXM signi cantly enhances the killing activity of PM N cells [121, 123] .
The interaction of PM N cells with C. neoform ans or its capsular component may also release pro-in ammatory cytokines. R ecently we reported that neutrop hils from healthy donor s secrete IL-1, TN F -a and IL-8 in response to encapsulated C. neoformans ; such stimulation also occurs with puri ed G XM alone [110] . Indeed, activation of the alternative complement pathway generates C3a and C5a fractions, responsible for PM N-induced cytokine release [124] .
Studies from M urphy's group have shown chemotactic activity for GXM in the presence or absence of serum [125] . H owever, the extent to which this effect contr ibutes to in ammation in ×i×o is not clear. In fact, recent data indicate that G XM induces L -selectin shedding from the neutrop hil surface. G iven that L -selectin is a molecule that transport s neutr ophils into tissue, this may prevent neutrop hil migration [126] . Inhibition of leukocyte in ltration into in ammatory sites may also be the result of binding of G XM to CD18 on human PM N, blocking the interaction of CD18 with its ligand on the endothelium [127] . The inhibitory effect of GXM on PM N migration has been report ed using IL-8 as a chemoattactant [111] .
T cell response
It is well established that the developm ent of an adequa te Th1 response is protective against C. neoformans [104, 128] and that Th1 and Th2 responses may coexist in the infected host for a period of time before one or the other dominates [129] . Biased Th2 generation may be related to the presence of the polysa ccharide capsule. This is support ed by the observations that capsular material decreased IF N -g and increased IL-4 secretion by T cells [130] , decreased IL-12 [85] and increased IL-10 production [90] by monocytes.
Capsular polysa ccharide exerts a series of suppressive effects on T cells [87] and affects lymphocyte response [88, 131] . As described above, the major effect of GXM results from its interaction with APC, which through cytokine secretion and costimulatory molecule expression strongly in uences T-cell activation and differentiation. In line with these data, Syme et al. [117] reported that capsular polysa ccharide inhibits lymphopr oliferation by inhibiting phagocyto sis. Blackstock [131] demonstr ated that cryptococcal polysa ccharide uses APCs to induce secretion of suppressor factor from T cells. The role of APCs is further stressed in a report by Blackstock & Casadevall [132] showing that activated APC treated with G XM are required to inhibit the cell suppressor response and to enhance the delayed type hypersensitivit y (D TH ) response. The Th1 response plays a major role in protection against C. neoformans. It is likely that the drive to develop and maintain the Th1 response is strongly in uenced by the presence of capsular material, in particular G XM .
Immunoregulation by GalXM and MP
G alXM and M P are minor components of C. neoformans capsular material. Indirect evidence suggest s that G alXM and M P are present in sera of patients with cryptococcosis [21] . The role of G alXM in pathogenicity is unknown . The interaction of GalXM and M P with the cellular immune system has been poorly explor ed relative to G XM . H owever, a regulatory role for these two fractions has been identi ed. Production of TN F -a has been observed after stimulation of leukocytes with G alXM , and M P and monocytes represent the major source of this cytokine [108, 112] . Chaka et al. [109] expanded these results and demonstr ated that, in contrast to the case with G XM , stimulation of GalXM and M P induced TNF -a secretion from peripheral blood mononuclear cells (PBM C), independen tly of the intact complement system. M ore recently we demonstr ated that M P is a strong inducer of IL-12 from human monocytes [114] . Since IL-12 is involved in the induction of a protective response to C. neoformans [104, 133] , M P may contribute to the establishment of a protective response against the fungus.
The interaction of GalXM and M P with PM N has been explored by Doug & M urphy [125] . It was found that GalXM and M P (as is the case for G XM ) prevent PM N accumulation at in ammation sites [134] . This might suggest that G alXM and M P modulate PM N activity and is suppor ted by the fact that G alXM binds CD18 receptor on the PM N surface [127] .
In contrast with G XM , M P and GalXM do not directly induce loss of L -selectins in the absence of serum [126] , suggesting that G alXM could activate the complement cascade by generation of C5a, which promotes L -selectin shedding from PM N [135] . The effect of M P on the T cell response has been studied [136] . There is evidence that, unlike GXM and GalXM , M P elicits a D TH response [137] . In addit ion, a role suppor ting T cell activation has been observed [114, 138, 139] .
Overall, G alXM shares biological activity with GXM , such as binding to PM N CD 18 receptors, and also shares some effects with M P, such as the inability to induce loss of selectin shedding on PM N [126, 127] , and to induce TNF by PBM C independently in the presence of an intact complement system [113] . However, its role in the pathogenesis of cryptococcosis is unclear. M P promotes a positive immune response to C. neoformans, inducing pro-in ammatory cytokines, a DTH response, T cell activation, and promotion of Th1 through prompt and massive stimulation of IL-12 release. M P may be a promising candida te in promoting a protective T cell response against C. neoformans.
Concluding remarks
R ecent studies on the capsular components of C. neoformans have provided importa nt data delineating the immunoregula tory role of G XM , GalXM and M P. G XM appears to be a barrier for optimal developm ent of the protective immune response to C. neoformans through inhibition of the phlogistic process and suppr ession of T cell activation. The deleterious effect of G XM on APCs may lead to new insights on the complexity of GXM in establishing T cell hypor esponsiveness or inappropr iate responsiveness. The manipula tion of APC reactivity may be bene cial in compensating for the immunosup pressive properties of GXM . M P induces secretion of critical cytokines apt to promote T cell expansion and Th1 type response. The immunor egulatory role of GalXM is similar to that of GXM in promoting L -selectin shedding by PM N or of M P in inducing DTH response. However, there are many unanswered questions on the in ×i×o role of GXM in hinder ing the Th1 response and the role of M P in promoting a cytokine storm that fuels the protective response. N evertheless, a better underst anding of these interactions may be exploited to facilitate, control, and improve the cellular immune response to C. neoformans through manipula tion of positive and negative fractions of capsular material in the infected host.
